Work status and return to work after treatment for bladder, prostate, and kidney cancers and urinary stones
Official title: Occupational Situation of Patients With Urological Diseases and Return to Work in Patients Undergoing Major Uro-Oncological Operations and Procedures for Urinary Tract Stones
Run by Jagiellonian University · NCT07088536 · Data updated 2026-11-12
This project will test how treatment for bladder, prostate, or kidney cancer and procedures for urinary stones affect whether adult patients can return to work and their quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | Jagiellonian University Academic / other |
| Locations | 1 site (Krakow, Malopolska) |
| Status | Recruiting |
| Started | July 21, 2025 |
| Main results expected | December 2026 |
| Study ends | April 2027 |
| Registry record updated | March 3, 2026 |
| Trial ID | NCT07088536 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults (≥18) admitted to the Department of Urology at Jagiellonian University Medical College during the six-month enrollment who are employed and undergoing major uro-oncological surgery or a urinary stone procedure for the prospective follow-up, while all admitted adults are eligible for the baseline survey.
✕Probably not a fit
Patients who are unemployed, retired, not undergoing major uro-oncological surgery or stone procedures, or treated outside the Kraków center are unlikely to receive direct benefit from the prospective follow-up data.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Over a six-month period at Jagiellonian University Medical College in Kraków, all adult urology admissions will complete a baseline survey about their occupational situation. A prospective subgroup of employed patients undergoing major uro-oncological surgeries or procedures for urinary stones will also complete quality-of-life questionnaires and receive phone follow-up at 3 and 6 months. The study combines a cross-sectional baseline capture with short-term longitudinal follow-up to track return-to-work outcomes and changes in well-being. Results will be used to identify barriers to returning to work and inform support and rehabilitation strategies for urological patients.
Why it matters
Potential benefit: If successful, the findings could help hospitals design targeted support and rehabilitation to improve return-to-work rates and quality of life for urology patients.
How similar studies have gone: Previous cancer survivorship studies using questionnaires and short-term follow-up have identified return-to-work barriers and informed rehabilitation programs, but focused, systematic data specific to major urological surgeries are relatively limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Adult patients (≥18 years) admitted to the Department of Urology and Oncological Urology, University Hospital in Kraków, during the 6-month study period. 2. For the prospective follow-up cohort: 1. Occupationally active (employed) at baseline. 2. Undergoing major uro-oncological surgery (e.g., radical cystectomy, radical prostatectomy, nephrectomy) or a procedure for urinary tract stones (e.g., ureterorenoscopy, percutaneous nephrolithotripsy). 3. Able and willing to provide written informed consent. Exclusion Criteria: 1. Patients unwilling or unable to provide informed consent. 2. Patients who are unemployed or retired at baseline (excluded from the prospective follow-up cohort but included in the baseline cross-sectional survey). 3. Patients not undergoing major uro-oncological surgery or urinary tract stone procedures (for the prospective follow-up cohort).
Where it's running
-
Jagiellonian University Medical College
Krakow, Malopolska, Poland Recruiting
Study contacts
- Study coordinator: Anna K. Czech, M.D., Ph.D.
- Email: aka.czech@uj.edu.pl
- Phone: +48124002500
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Irreversible Electroporation for Recurrent Pelvic Tumors
This study tests whether using irreversible electroporation (IRE) is safe and helps control recurrent pelvic tumors in adults who can’t have other local treatments.
-
AI assistant to help diagnose and treat urological diseases
A large language model-based AI tool called UroAgent will be developed and tested to help doctors diagnose and plan treatment for urinary stones, prostate cancer, and bladder cancer using past records and new patient data.
-
SL-28 for Advanced Solid Tumours
A new allogeneic cell therapy called SL-28 is being tested in adults with advanced solid tumors to see if it is safe and can help shrink tumors.
-
Mobile health outreach for men's cancer screening
This study is testing a mobile health service that brings cancer screening directly to men at their workplaces, especially those in high-risk groups, to help them get checked for prostate cancer and other urological issues.
-
Validation of a blood test for early cancer detection and monitoring
This study is testing a blood test to see if it can help find different types of cancer early and monitor patients after treatment.
-
Evaluating progastrin levels in cancer patients
This study is testing if measuring progastrin levels in the blood can help predict how cancer will progress and respond to treatment in patients with different types of cancer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.